Krecak相关文献与解析，生知库 | 链接生命科学的每一步

Lucijanic, Marko; Krecak, Ivan; Soric, Ena; Sabljic, Anica; Galusic, Davor; Holik, Hrvoje; Perisa, Vlatka; Moric Peric, Martina; Zekanovic, Ivan; Budimir, Leonardo; Kusec, Rajko

血小板

发表日期：2025

文献求助收藏

Is There a Role for Daratumumab Retreatment in Patients with Relapsed/Refractory Multiple Myeloma?

达雷妥尤单抗再治疗在复发/难治性多发性骨髓瘤患者中是否发挥作用？

期刊:Biomedicines

影响因子:3.9

doi:10.3390/biomedicines13010207

Galusic, Davor; Krecak, Ivan; Blaslov, Viktor; Krstulovic Opara, Andela; Valkovic, Toni; Basic Kinda, Sandra

Development and Validation of the CARRA-VID Prognostic Score: C Reactive Protein to Albumin Ratio, Red Blood Cell Distribution Width and Age-Based Score for Prognostication of Hospitalized COVID-19 Patients

CARRA-VID预后评分的开发与验证：C反应蛋白与白蛋白比值、红细胞分布宽度和基于年龄的评分用于预测住院COVID-19患者的预后

期刊:Viruses-Basel

影响因子:3.5

doi:10.3390/v17050629

Lucijanic, Marko; Piskac Zivkovic, Nevenka; Busic, Nikolina; Stojic, Josip; Atic, Armin; Derek, Lovorka; Krecak, Ivan; Barsic, Bruno; Luksic, Ivica

Survey of Clinical Practice in Chronic Myeloproliferative Neoplasms in Croatia: A Study by the MPN Working Group Party of the Croatian Cooperative Group for Hematologic Diseases (KROHEM)

克罗地亚慢性骨髓增生性肿瘤临床实践调查：克罗地亚血液病合作组 (KROHEM) MPN 工作组的一项研究

期刊:Journal of Clinical Medicine

影响因子:2.9

doi:10.3390/jcm14051524

Krecak, Ivan; Lucijanic, Marko; Kusec, Rajko

Prevalence of Chronic Obstructive Pulmonary Disease and Asthma in Polycythemia Vera and Essential Thrombocythemia and Its Prognostic Implications

真性红细胞增多症和原发性血小板增多症患者慢性阻塞性肺疾病和哮喘的患病率及其预后意义

期刊:Journal of Clinical Medicine

影响因子:2.9

doi:10.3390/jcm14238416

Krecak, Ivan; Lekovic, Danijela; Arsenovic, Isidora; Dabcevic, Nina; Ivankovic, Iva; Holik, Hrvoje; Zekanovic, Ivan; Moric Peric, Martina; Matic, Andrea Anic; Bogdanovic, Andrija; Skelin, Marko; Lucijanic, Marko

The effect of impaired renal function, increased red cell mass and plasma volume on thrombotic risk in PV patients

肾功能受损、红细胞数量和血浆容量增加对真性红细胞增多症患者血栓形成风险的影响

期刊:Annals of Hematology

影响因子:2.4

doi:10.1007/s00277-025-06348-4

Lucijanic, Marko; Lekovic, Danijela; Bogdanovic, Andrija; Krecak, Ivan

Polo-like Kinase 1 Expression as a Biomarker in Colorectal Cancer: A Retrospective Two-Center Study

Polo 样激酶 1 表达作为结直肠癌的生物标志物：一项回顾性双中心研究

期刊:Biomedicines

影响因子:3.9

doi:10.3390/biomedicines13010054

Lana Jajac Brucic, Vesna Bisof, Majana Soce, Marko Skelin, Ivan Krecak, Andjela Nadinic, Branka Vrbicic, Zivana Puljiz, Suzana Hancic, Slavko Gasparov

Evaluation of Absolute Neutrophil, Lymphocyte and Platelet Count and Their Ratios as Predictors of Thrombotic Risk in Patients with Prefibrotic and Overt Myelofibrosis

评估绝对中性粒细胞、淋巴细胞和血小板计数及其比值作为前纤维化和显性骨髓纤维化患者血栓风险预测指标的价值

期刊:Life-Basel

影响因子:3.4

doi:10.3390/life14040523

Lucijanic, Marko; Krecak, Ivan; Soric, Ena; Sabljic, Anica; Galusic, Davor; Holik, Hrvoje; Perisa, Vlatka; Moric Peric, Martina; Zekanovic, Ivan; Budimir, Josipa; Kusec, Rajko

Systemic Inflammatory Index in Polycythemia Vera and Its Prognostic Implications

真性红细胞增多症的系统性炎症指数及其预后意义

期刊:Journal of Clinical Medicine

影响因子:2.9

doi:10.3390/jcm13154459

Krecak, Ivan; Lekovic, Danijela; Arsenovic, Isidora; Bogdanovic, Andrija; Holik, Hrvoje; Zekanovic, Ivan; Moric Peric, Martina; Lucijanic, Marko

Prognosis of MPN Patients Experiencing Acute Thrombotic Events and the Potential Role of Cytoreduction

MPN患者发生急性血栓事件的预后及细胞减灭疗法的潜在作用

期刊:Jacc: Cardiooncology

影响因子:12.8

doi:10.1016/j.jaccao.2023.08.009

Krecak, Ivan; Lucijanic, Marko

Extreme Thrombocytosis in Patients with Overt Myelofibrosis and Its Clinical Associations

骨髓纤维化患者的极度血小板增多症及其临床关联

Is There a Role for Daratumumab Retreatment in Patients with Relapsed/Refractory Multiple Myeloma?

达雷妥尤单抗再治疗在复发/难治性多发性骨髓瘤患者中是否发挥作用？

Development and Validation of the CARRA-VID Prognostic Score: C Reactive Protein to Albumin Ratio, Red Blood Cell Distribution Width and Age-Based Score for Prognostication of Hospitalized COVID-19 Patients

CARRA-VID预后评分的开发与验证：C反应蛋白与白蛋白比值、红细胞分布宽度和基于年龄的评分用于预测住院COVID-19患者的预后

Survey of Clinical Practice in Chronic Myeloproliferative Neoplasms in Croatia: A Study by the MPN Working Group Party of the Croatian Cooperative Group for Hematologic Diseases (KROHEM)

克罗地亚慢性骨髓增生性肿瘤临床实践调查：克罗地亚血液病合作组 (KROHEM) MPN 工作组的一项研究

Prevalence of Chronic Obstructive Pulmonary Disease and Asthma in Polycythemia Vera and Essential Thrombocythemia and Its Prognostic Implications

真性红细胞增多症和原发性血小板增多症患者慢性阻塞性肺疾病和哮喘的患病率及其预后意义

The effect of impaired renal function, increased red cell mass and plasma volume on thrombotic risk in PV patients

肾功能受损、红细胞数量和血浆容量增加对真性红细胞增多症患者血栓形成风险的影响

Polo-like Kinase 1 Expression as a Biomarker in Colorectal Cancer: A Retrospective Two-Center Study

Polo 样激酶 1 表达作为结直肠癌的生物标志物：一项回顾性双中心研究

Evaluation of Absolute Neutrophil, Lymphocyte and Platelet Count and Their Ratios as Predictors of Thrombotic Risk in Patients with Prefibrotic and Overt Myelofibrosis

评估绝对中性粒细胞、淋巴细胞和血小板计数及其比值作为前纤维化和显性骨髓纤维化患者血栓风险预测指标的价值

Systemic Inflammatory Index in Polycythemia Vera and Its Prognostic Implications

真性红细胞增多症的系统性炎症指数及其预后意义

Prognosis of MPN Patients Experiencing Acute Thrombotic Events and the Potential Role of Cytoreduction

MPN患者发生急性血栓事件的预后及细胞减灭疗法的潜在作用